{
  "docId": "019de070-fbaf-759b-8cbd-9f18172b1352",
  "docSlug": "7d8ead18d80cb869cda17e33a74aeb0b",
  "documentTitle": "BioNTech | Results Presentation Deck | 30 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 30,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "other",
  "function": "present_framework",
  "density": "balanced",
  "nDataPoints": 2,
  "notes": "Uses a process-flow diagram to illustrate the integration of R&D, manufacturing, and commercialization.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de070-fbaf-759b-8cbd-9f18172b1352/5",
  "deckHref": "/decks/019de070-fbaf-759b-8cbd-9f18172b1352",
  "deckJsonHref": "/decks/019de070-fbaf-759b-8cbd-9f18172b1352.json",
  "deckAnchorHref": "/decks/019de070-fbaf-759b-8cbd-9f18172b1352#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.9,
        "x": 0.05,
        "y": 0.18
      },
      "kind": "diagram",
      "text": "Flow from core capabilities to pipeline to commercial launch",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "858c5cb4-f820-4866-8de6-dfefd44baa2f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.25,
        "x": 0.05,
        "y": 0.2
      },
      "kind": "list",
      "text": "Deep Immunology Expertise, Broad Suite of Novel Technologies, Bioinformatics Approach, In-House Manufacturing, Commercial Capabilities, Global Team of 2,000+",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7509b1e6-bc20-477d-98da-056884b41cfd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.05,
        "x": 0.5,
        "y": 0.25
      },
      "kind": "metric",
      "text": "20+",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "656a8db9-74ae-407c-8f9f-4cbdd47a6e58",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.04,
        "y": 0.09
      },
      "kind": "title",
      "text": "Transformed into a Fully Integrated, Global Immunotherapy Company",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "555e8635-3546-4360-888b-a2c1894337b2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "value-chain",
      "slug": null,
      "matchId": "dca9b68b-bd2d-489f-bb2d-9943cd8b02bc",
      "evidence": "The slide maps internal capabilities to output and market outcomes.",
      "confidence": 0.85
    }
  ],
  "arcBeats": [
    {
      "to": 8,
      "from": 5,
      "beatId": "15479899-563a-454d-9308-df3dd803567b",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The deck highlights the company's transformation and focus on COVID-19 vaccine reach",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 16,
      "from": 5,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "acfebc91-ffe5-4ab0-8668-9619a540ee49",
      "evidence": "The deck explains the company's approach to immunotherapy and its potential",
      "position": 0,
      "objective": "Why BioNTech's immunotherapy approach is effective",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.6,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}